Steele Smith III

Idrasil, a cannabis-based tablet aimed at the medical community, is at the center of a long-running lawsuit filed by the Securities and Exchange Commission against a California cannabis company. The SEC alleges fraud and investor losses in the lawsuit, filed Sept. 28, 2021 against C3 International...